Новые достижения в диагностике и лечении фибрилляции предсердий: от экспериментальных исследований до повседневной клинической практики
Новые достижения в диагностике и лечении фибрилляции предсердий: от экспериментальных исследований до повседневной клинической практики
Миронов Н.Ю., Лайович Л.Ю., Миронова Е.С. и др. Новые достижения в диагностике и лечении фибрилляции предсердий: от экспериментальных исследований до повседневной клинической практики. Терапевтический архив. 2019; 91 (6): 11–18. DOI: 10.26442/00403660.2019.06.000295
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Нарушения ритма сердца – широко распространенное клиническое явление. Их возникновение может быть обусловлено практически любым видом сердечной патологии. Фибрилляция предсердий (ФП) является наиболее распространенной формой нарушений ритма сердца. Распространенность ФП в общей популяции составляет 1–2%, и продолжающийся рост заболеваемости позволяет прогнозировать удвоение количества больных в течение ближайших 50 лет. В данном обзоре представлены новейшие диагностические методики и методы лечения, включающие как уникальные отечественные антиаритмические препараты, так и немедикаментозные методы лечения ФП, разработанные и внедренные в клиническую практику в НМИЦ кардиологии Минздрава России.
Ключевые слова: фибрилляция предсердий, антиаритмические препараты, кардиоверсия, аутоантитела, воспаление, фиброз, магнитно-резонансная томография, криоаблация, синдром обструктивного апноэ сна.
Keywords: atrial fibrillation, antiarrhythmic drugs, cardioversion, autoantibodies, inflammation, fibrosis, magnetic resonance imaging, cryoablation, obstructive sleep apnea syndrome.
Ключевые слова: фибрилляция предсердий, антиаритмические препараты, кардиоверсия, аутоантитела, воспаление, фиброз, магнитно-резонансная томография, криоаблация, синдром обструктивного апноэ сна.
________________________________________________
Keywords: atrial fibrillation, antiarrhythmic drugs, cardioversion, autoantibodies, inflammation, fibrosis, magnetic resonance imaging, cryoablation, obstructive sleep apnea syndrome.
Список литературы
1. Ревишвили А.Ш., Шляхто Е.В., Сулимов В.А., Рзаев Ф.Г., Горев М.В., Нардая Ш.Г., Шпектор А.В., Голицын С.П., Попов С.В., Шубик Ю.В., Яшин С.М., Михайлов Е.Н., Покушалов Е.А., Гиляров М.Ю., Лебедев Д.С., Андреев Д.А., Баталов Р.Е., Пиданов О.Ю., Медведев М.М., Новикова Н.А. Диагностика и лечение фибрилляции предсердий. Клинические рекомендации. М.: Всероссийское научное общество специалистов по клинической электрофизиологии, аритмологии и кардиостимуляции, 2017. 211 с. [Revishvili ASh, Shlyakhto EV, Sulimov VA, Rzaev FG, Gorev MV, Nardaya ShG, Shpektor AV, Golitsyn SP, Popov SV, Shubik YuV, Yashion SM, Mikhailov EN, Pokushalov EA, Gilyarov MYu, Lebedev DS, Andreev DA, Batalov RE, Pidanov OYu, Medvedev MM, Novikova NA. Diagnostika i lechenie fibrillyatsii predserdiy. Klinicheskie rekomendatsii [Atrial fibrillation: diagnosis and management. Clinical practice guidelines]. Moscow: Russian clinical electrophysiology, arrhythmology and cardiac pacing society, 2017 (In Russ.)].
2. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW; ACC/AHA Task Force Members. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. J Am Coll Cardiol. 2014;64(21):247-78. doi: 10.1161/CIR.0000000000000040
3. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P, Agewall S, Camm J, Baron Esquivias G, Budts W, Carerj S, Casselman, Coca A, De Caterina R, Deftereos S, Dobrev D, Ferro JM, Filippatos G, Fitzsimons D, Gorenek B, Guenoun M, Hohnloser SH, Kolh P, Lip GY, Manolis A, McMurray J, Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, Tamargo JL, Taylor CJ, Van Gelder IC, Voors AA, Windecker S, Zamorano JL, Zeppenfeld K. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18(11):1609-78. doi: 10.1093/europace/euw295
4. Пармон Е.В., Трешкур Т.В., Шляхто Е.В. Идиопатические желудочковые нарушения ритма (анализ проблемы). Вестник аритмологии. 2003;31:60-71 [Parmon EV, Treshkur TV, Shlyahto EV. Idiopathic ventricular arrhythmias (Problem analysis). Vestnik Aritmologii. 2003;31:60-71 (In Russ.)].
5. Родионова Е.С., Миронова Н.А., Апарина О.П., Рогова М.М., Зыков К.А., Голицын С.П. Роль аутоиммунных реакций в развитии нарушений ритма и проводимости сердца. Терапевтический архив. 2012;(4):74-8 [Rodionova ES, Mironova NA, Aparina OP, Rogova MM, Zykov KA, Golitsyn SP. Role of autoimmune reactions in development of cardiac arrhythmia and conduction disturbances. Therapeutic Archive. 2012;(4):74-8 (In Russ.)].
6. Zaho R, Wang W, Wu B, Hoebeke J, Hjalmarson A, Fu ML. Effects of anti-peptide antibodies against the second extracellular loop of human M2 muscarinic acetylcholine receptors on transmembrane potentials and currents in guinea pig ventricular myocytes. Mol Cell Biochem J. 1994;163:185-93.
7. Stavrakis S, Kem DC. Activating autoantibodies to the beta1-adrenergic and M2 muscarinic receptors facilitate atrial fibrillation in patients with Graves’ hyperthyroidism. J Am Coll Cardiol. 2009;54:1309-16.
8. Костюкевич М.В., Зыков К.А., Миронова Н.А., Агапова О.Ю., Шевелев А.Я., Ефремов Е.Е., Власик Т.Н., Голицын С.П. Роль аутоантител к β1-адренорецептору при сердечно-сосудистых заболеваниях. Кардиология. 2016;56(12):82-91 [Kostyukevich MV, Zykov KA, Mironova NA, Agapova OYu, Shevelev AYa, Efremov EE, Vlasik TN, Golitsyn SP. Role of Autoantibodies Against β1-Adrenergic Receptor in Cardiovascular Disease. Kardiologiia. 2016;56(12):82-91 (In Russ.)]. doi: 10.18565/cardio.2016.12.82-91
9. Чазов Е.И. Некоторые аспекты диагностики и лечения сердечно-сосудистых заболеваний. Терапевтический архив. 1991;63(9):6 [Chazov EI. Issues in diagnosis and management of cardiovascular diseases. Therapeutic Archive. 1991;63(9):6 (In Russ.)].
10. Палькеева М.Е., Сидорова М.В., Молокоедов А.С., Азьмуко А.А., Беспалова Ж.Д., Шарф Т.В., Мамочкина Е.Н., Ефремов Е.Е., Рогова М.М., Миронова Н.А., Зыков К.А., Голицын С.П. Синтетический конформационный антиген, моделирующий внеклеточную часть мускаринового М2-рецептора, и его взаимодействие с сыворотками крови пациентов с идиопатическими аритмиями. Биоорганическая химия. 2013;39(3):285 [Palkeeva ME, Sidorova MV, Molokoedov AS, Az'muko AA, Bespalova ZhD, Sharf TV, Mamochkina EN, Efremov EE, Rogova MM, Mironova NA, Zykov KA, Golitsyn SP. Synthetic conformational antigen which simulates the extracellular part of the M2-muscarinic receptor: Interaction with blood sera of patients suffering from idiopathic arrhythmias. Bioorganicheskaya khimiya = Russ J Bioorg Chem. 2013;39(3):252-8 (In Russ.)]. doi: 10.7868/S013234231303010X
11. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997;96 (4):1180-4.
12. Morillo CA, Klein GJ, Jones DL, Guiraudon CM. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation. 1995;91(5):1588-95.
13. Апарина О.П., Чихирева Л.Н., Миронова Н.А., Миронова Е.С., Бакалов С.А. Роль структурно-функциональных изменений предсердий в развитии и прогрессировании фибрилляции предсердий. Терапевтический архив. 2014;86(1):71-7 [Aparina OP, Chikhireva LN, Mironova NA, Mironova ES, Bakalov SA. Role of atrial structural and functional changes in the development and progression of atrial fibrillation. Therapeutic Archive. 2014;86(1):71-7 (In Russ.)].
14. Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen SA, Chugh SS, Corradi D, A DA, Dobrev D, Fenelon G, Gonzalez M, Hatem SN, Helm R, Hindricks G, Ho SY, Hoit B, Jalife J, Kim YH, Lip GY, Ma CS, Marcus GM, Murray K, Nogami A, Sanders P, Uribe W, van Wagoner DR, Nattel S. Ehra/hrs/aphrs/solaece expert consensus on atrial cardiomyopathies: Definition, characterisation, and clinical implication. J Arrhythm. 2016;32(4):247-78. doi: 10.1016/j.joa.2016.05.002
15. Flett AS, Hasleton J, Cook C, Hausenloy D, Quarta G, Ariti C, Muthurangu V, Moon JC. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc Imaging. 2011;4(2):150-6. doi: 10.1016/j.jcmg.2010.11.015
16. Kim RJ, Albert TS, Wible JH, Elliott MD, Allen JC, Lee JC, Parker M, Napoli A, Judd RM. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: An international, multicenter, double-blinded, randomized trial. Circulation. 2008;117(5):629-37. doi: 10.1161/CIRCULATIONAHA.107.723262
17. Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, Fish EN, Blauer JJ, Rao SN, DiBella EV, Segerson NM, Daccarett M, Windfelder J, McGann CJ, Parker D, MacLeod RS, Marrouche NF. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation. 2009;119(13):1758-67. doi: 10.1161/CIRCULATIONAHA.108.811877
18. Karim R, Housden RJ, Balasubramaniam M, Chen Z, Perry D, Uddin A, Al-Beyatti Y, Palkhi E, Acheampong P, Obom S, Hennemuth A, Lu Y, Bai W, Shi W, Gao Y, Peitgen HO, Radau P, Razavi R, Tannenbaum A, Rueckert D, Cates J, Schaeffter T, Peters D, MacLeod R, Rhode K. Evaluation of current algorithms for segmentation of scar tissue from late gadolinium enhancement cardiovascular magnetic resonance of the left atrium: An open-access grand challenge. J Cardiovasc Magn Reson. 2013;15:105. doi: 10.1186/1532-429X-15-105
19. Апарина ОП, Стукалова ОВ, Пархоменко ДВ, Миронова НА, Буторова ЕА, Болотова МН, Макеев МИ, Терновой СК, Голицын СП. Характеристика структуры миокарда левого предсердия у больных мерцательной аритмией и здоровых добровольцев по данным магнитно-резонансной томографии с отсроченным контрастированием. Вестник аритмологии. 2014;77:5-12 [Aparina OP, Stukalova OV, Parkhomenko DV, Mironova NA, Butorova EA, Bolotova MN, Makeev MI, Ternovoy SK, Golitsyn SP. Characteristics of left atrial myocardium structure in tarial fibrillation and healthy volunteers according to late gadolinium enhancement magnetic resonanse imaging. Vestnik Aritmologii. 2014;77:5-12 (In Russ.)].
20. Апарина О.П., Стукалова О.В., Пархоменко Д.В., Миронова Н.А., Страздень Е.Ю., Терновой С.К., Голицын С.П. Структурно-функциональные характеритики левого предсерлия у здоровых добровольцев и пациентов с фибрилляцией предсердий по данным магнитно-резонанасной томографии с отсроченным контрастированием. Кардиология. 2017;59(9):5-13 [Aparina OP, Stukalova OV, Parkhomenko DV, Mironova NA, Strzdenj EYu, Ternovoy SK, Golitsyn SP. Structural and functional properties of the left atrium in healthy volunteers and patients with atrial fibrillation: data of madnetic resonance imaging. Kardiologiia. 2017;59(9):5-13 (In Russ.)]. doi: 10.18087/cardio.2017.9.10029
21. Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, Kholmovski E, Burgon N, Hu N, Mont L, Deneke T, Duytschaever M, Neumann T, Mansour M, Mahnkopf C, Herweg B, Daoud E, Wissner E, Bansmann P, Brachmann J. Association of atrial tissue fibrosis identified by delayed enhancement mri and atrial fibrillation catheter ablation: The decaaf study. JAMA. 2014;311(5):498-506. doi: 10.1001/jama.2014.3
22. Platonov PG, Mitrofanova LB, Orshanskaya V, Ho SY. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J Am Coll Cardiol. 2011;58 (21):2225-32. doi: 10.1016/j.jacc.2011.05.061
23. Kuppahally SS, Akoum N, Burgon NS, Badger TJ, Kholmovski EG, Vijayakumar S, Rao SN, Blauer J, Fish EN, Dibella EV, Macleod RS, McGann C, Litwin SE, Marrouche NF. Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: Relationship to left atrial structural remodeling detected by delayed-enhancement MRI. Circ Cardiovasc Imaging. 2010;3(3):231-9. doi: 10.1161/CIRCIMAGING.109.865683
24. Peters DC, Wylie JV, Hauser TH, Kissinger KV, Botnar RM, Essebag V, Josephson ME, Manning WJ. Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement mr imaging: Initial experience. Radiology. 2007;243 (3):690-5. doi: 10.1148/radiol.2433060417
25. Wijffels MC, Kirchhof CJ, Dorland R, et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92:1954-68.
26. Брегвадзе И.Н., Майков Е.Б., Бильдинов О.А., Голицын С.П. Эффективность и безопасность нибентана при медикаментозной кардиоверсии у больных персистирующей формой фибрилляции и трепетания предсердий: роль ограничения доз препарата и применения магния сульфата. Кардиология. 2007;(3):48-55 [Bregvadze IN, Maykov EB, Bildinov OA, Golitsyn SP. Efficacy and safety of nibentan in conversion of persistent atrial fibrillation and flutter to sinus rhythm: role of dose limitation and magnesium sulfate. Kardiologiia. 2007;(3):48-55 (In Russ.)].
27. Меркулова И.Н., Тарарак А.Э., Коткин К.Л., Голицын С.П., Руда М.Я. Клиническое изучение нибентана – нового антиаритмического препарата III класса. Сообщение 3. Эффективность нибентана у больных с желудочковыми нарушениями ритма сердца, аритмогенные эффекты. Кардиология. 1997;(4):3-14 [Merkulova IN, Tararak AE, Kotkin KL, Golitsyn SP, Ruda MYa. Clinical investigation of new class III antiarrhythmic drug nibentan. Message 3: Efficacy of nibentan in ventricular arrhythmias, proarrhythmic effects. Kardiologiia. 1997;(4):3-14 (In Russ.)].
28. Глушков Р.Г., Южаков С.Д., Львов А.И., Жихарева Г.П., Давыдова Н.К., Сизова О.С., Аснина В.В., Салин Е.Н. Новая группа антиаритмических средств III класса – производных пиперидил-4-этана. Химико-фармацевтический журнал. 2011;45(2):3-12 [Glushkov RG, Yuzhakov SD, L'vov AI, Zhikhareva GP, Davydova NK, Sizova OS, Asnina VV, Salin EN. New group of class III antiarrhythmic drugs: Piperid-4-ylethane derivatives. Khimiko-Farmatsevticheskii Zhurnal = Pharmaceutical Chemistry Journal. 2011;45(2):65-74 (In Russ.)].
29. Розенштраух Л.В., Федоров В.В., Резник А.В., Шарифов О.Ф., Белошапко Г.Г., Юшманова А.В., Голицын С.П., Руда М.Я., Чазов Е.И. Экспериментальное электрофизиологическое исследование препарата III класса РГ-2. Кардиология. 2003;43(9):56-64 [Rosenstraukh LV, Fedorov VV, Reznik AV, Sharifov OF, Beloshapko GG, Yushmanova AV, Golitsyn SP, Ruda MYa, Chazov EI. Electrophysiological Experimental Study of a Novel Class III Antiarrhythmic Drug RG-2. Kardiologiia. 2003;43(9):56-64 (In Russ.)].
30. Миронов Н.Ю., Голицын С.П., Соколов С.Ф., Майков Е.Б., Шлевков Н.Б., Юричева Ю.А., Мареев Ю.В., Розенштраух Л.В., Чазов Е.И. Электрофизиологические эффекты и противоаритмическая активность нового отечественного антиаритмического препарата III класса ниферидила у больных пароксизмальными наджелудочковыми тахикардиями. Экспериментальная и клиническая фармакология. 2012;75(10):16-21 [Mironov NYu, Golitsyn SP, Sokolov SF, Maikov EB, Shlevkov NB, Yuricheva YuA, Mareev YuV, Rozenshtraukh LV, Chazov EI. Electrophysiological Effects and Antiarrhythmic Activity of Novel Domestic Class III Antiarrhythmogenic Drug Niferidil Administered in Patients with Paroxismal Supraventricular Tachycardia. Eksperimental'naya i Klinicheskaya Farmakologiya = Experimental and Clinical Pharmacology. 2012;75(10):16-21 (In Russ.)].
31. Юричева Ю.А., Соколов С.Ф., Голицын С.П., Миронов Н.Ю., Ривин А.Е., Берман М.В., Шубик Ю.В., Зотова И.В., Затейщиков Д.А., Болотова М.Н., Розенштраух Л.В., Чазов Е.И. Новый антиаритмический препарат III класса ниферидил как эффективное средство восстановления синусового ритма при персистирующей форме мерцательной аритмии. Вестник аритмологии. 2012;70:32-43 [Yuricheva YuA, Sokolov SF, Golitsyn SP, Mironov NYu, Rivin AE, Berman MV, Shubik YuV, Zotova IV, Zateyshchikov DA, Bolotova MN, Rozenshtraukh LV, Chazov EI. A novel III class antiarryhthmic, niferidil, as an effective medication for the sinus rhythm recovery in patients with persistent atrial fibrillation. Vestnik Aritmologii = J Arrhythmol. 2012;70:32-43 (In Russ.)].
32. Миронов Н.Ю., Влодзяновский В.В., Юричева Ю.А., Соколов С.Ф., Голицын С.П., Розенштраух Л.В., Чазов Е.И. Проспективное рандомизированное исследование эффективности и безопасности электрической и медикаментозной кардиоверсии при персистирующей фибрилляции предсердий. Часть 1: методология исследования и оценка эффективности. Рациональная фармакотерапия в кардиологии. 2018;14(5):664-9 [Mironov NYu, Vlodzyanovskiy VV, Yuricheva YuA, Sokolov SF, Golitsyn SP, Rosenstraukh LV, Chazov EI. Safety and effectiveness of electrical and pharmacological cardioversion in persistent atrial fibrillation. Part I: study rationale, design and assessment of effectiveness. Ratsional'naya Farmakoterapiya v Kardiologii = Ration Pharmacother Cardiol. 2018;14(5):664-9 (In Russ.)]. doi: 10.20996/1819-6446-2018-14-5-664-669
33. Миронов Н.Ю., Влодзяновский В.В., Юричева Ю.А., Соколов С.Ф., Голицын С.П., Розенштраух Л.В., Чазов Е.И. Проспективное рандомизированное исследование эффективности и безопасности электрической и медикаментозной кардиоверсии при персистирующей фибрилляции предсердий. Часть 2: оценка безопасности. Рациональная фармакотерапия в кардиологии. 2018;14(6):826-30 [Mironov NYu, Vlodzyanovskiy VV, Yuricheva YuA, Sokolov SF, Golitsyn SP, Rosenstraukh LV, Chazov EI. Safety and effectiveness of electrical and pharmacological cardioversion in persistent atrial fibrillation. Part 2: assessment of safety. Ratsional'naya Farmakoterapiya v Kardiologii = Ration Pharmacother Cardiol. 2018;14(6):826-30 (In Russ.)]. doi: 10.20996/1819-6446-2018-14-6-826-830
34. Миронов Н.Ю., Майков Е.Б., Шлевков Н.Б., Мареев Ю.В., Влодзяновский, Груздев К.А., Певзнер А.В. Катетерная баллонная криоаблация в лечении пароксизмальной формы фибрилляции предсердий: клиническая демонстрация возможностей методики. Кардиологический вестник. 2014;9(2):44-52 [Mironov NYu, Maykov EB, Shlevkov NB, Mareev YuV, Vlodzyanovskiy VV, Gruzdev KA, Pevzner AV. Catheter balloon cryoablation in management of paroxysmal atrial fibrillation: demonstration of clinical cases. Kardiologicheskii Vestnik = Bull Cardiol. 2014;9(2):44-52 (In Russ.)].
35. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D; Heart Rhythm Society Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm. 2012;9(4):632-96. doi: 10.1016/j.hrthm.2011.12.016
36. Packer DL, Kowal RC, Wheelan KR, Irwin JM, Champagne J, Guerra PG, Dubuc M, Reddy V, Nelson L, Holcomb RG, Lehmann JW, Ruskin JN; STOP AF Cryoablation Investigators. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol. 2013;61(16):1713-23. doi: 10.1016/j.jacc.2012.11.064
37. Garg J, Chaudhary R, Palaniswamy C, Shah N, Krishnamoorthy P, Bozorgnia B, Natale A. Cryoballoon versus radiofrequency ablation for atrial fibrillation: A meta-analysis of 16 clinical trials. J Atr Fibrillation. 2016;9(3):1429. doi: 10.4022/jafib.1429
38. Ciconte G, Baltogiannis G, de Asmundis C, Sieira J, Conte G, Di Giovanni G, Saitoh Y, Irfan G, Mugnai G, Hunuk B, Chierchia GB, Brugada P. Pulmonary vein isolation as index procedure for persistent atrial fibrillation: One-year clinical outcome after ablation using the second-generation cryoballoon. Heart Rhythm. 2015;12(1):60-6. doi: 10.1016/j.hrthm.2014.09.063
39. Aryana A, Baker JH, Espinosa Ginic MA, Pujara DK, Bowers MR, O'Neill PG, Ellenbogen KA, Di Biase L, d'Avila A, Natale A. Posterior wall isolation using the cryoballoon in conjunction with pulmonary vein ablation is superior to pulmonary vein isolation alone in patients with persistent atrial fibrillation: A multicenter experience. Heart Rhythm. 2018;15(8):1121-9. doi: 10.1016/j.hrthm.2018.05.014
40. Щербакова Н.В., Мешков А.Н., Бойцов С.А. Применение метода секвенирования экзомов для диагностики предрасположенности к комплексным заболеваниям в профилактической медицине. Кардиоваскулярная терапия и профилактика. 2013;12(6):24-8 [Shcherbakova NV, Meshkov AN, Boytsov SA. Exome sequencing and the diagnostics of complex disease predisposition in preventive medicine. Kardiovaskulyarnaya Terapiya i Profilaktika = Cardiovasc Ther Prof. 2013;12(6):24-8 (In Russ.)].
41. Акрамова Э.Г. Характеристика нарушений ритма сердца у больных хронической обструктивной болезнью легких. Клиническая медицина. 2013;91(2):41-4 [Akramova EG. Characteristic of cardiac rhythm disturbances in patients with chronic obstructive pulmonary disease. Klinicheskaya Meditsina = Clinical Medicine. 2013;91(2):41-4 (In Russ.)].
42. Долгушева Ю.А., Агапова О.Ю., Зыков К.А., Чазова И.Е. Безопасность применения β-адреномиметиков разной длительности действия у пациентов с артериальной гипертонией в сочетании с бронхообструктивными заболеваниями. Системные гипертензии. 2015;12(1):65-9 [Dolgusheva YuA, Agapova OYu, Zykov KA, Chazova IE. Safety of beta-agonists with different duration of action in patients with arterial hypertension and broncho-obstructive diseases. Sistemnye Gipertenzii = Systemic Hypertension. 2015;12(1):65-9 (In Russ.)].
43. Байрамбеков Э.Ш., Певзнер А.В., Литвин А.Ю., Фомичева О.А. Фибрилляция предсердий и длительные ночные "остановки" сердца у больного с синдромом обструктивного апноэ во сне. успешная коррекция нарушений при применении СИПАП-терапии. Терапевтический архив. 2016;88(9):84-9 [Bairambekov ESh, Pevzner AV, Litvin AYu, Fomicheva OA. Atrial fibrillation and prolonged nocturnal cardiac arrests in a patient with obstructive sleep apnea syndrome. Successful correction of disorders by CPAP therapy. Therapeutic Archive. 2016;88(9):84-9 (In Russ.)]. doi: 10.17116/terarkh201688984-89
44. Dimitri H, Ng M, Brooks AG, Kuklik P, Stiles MK, Lau DH, Antic N, Thornton A, Saint DA, McEvoy D, Antic R, Kalman JM, Sanders P. Atrial remodeling in obstructive sleep apnea: implications for atrial fibrillation. Heart Rhythm. 2012;9(3):321-7. doi: 10.1016/j.hrthm.2011.10.017
45. Байрамбеков Э.Ш., Певзнер А.В., Литвин А.Ю., Елфимова Е.М. Возможности диагностики и частота выявления синдрома обструктивного апноэ во время сна у больных с различными формами фибрилляции предсердий. Кардиологический вестник. 2016;11(2):34-41 [Bairambekov ESh, Pevzner AV, Litvin AYu, Elfimova EM. Possibilities of diagnostics and the detection rate of obstructive sleep apnea in patients with various forms of atrial fibrillation. Kardiologicheskii Vestnik = Bull Cardiol. 2016;11(2):34-41 (In Russ.)].
46. Певзнер А.В., Байрамбеков Э.Ш., Литвин А.Ю., Елфимова Е.М., Ермишкин В.В., Соколов С.Ф., Голицын С.П. Результаты применения терапии с созданием постоянного положительного давления воздуха в верхних дыхательных путях при лечении больных с фибрилляцией предсердий и синдромом обструктивного апноэ во время сна. Российский кардиологический журнал. 2017;22(7):111-6 [Pevzner AV, Bayrambekov ESh, Litvin AYu, Elfimova EM, Ermishkin VV, Sokolov SF, Golitsyn SP. Results of continuous positive upper airway pressure treatment in patients with atrial fibrillation and obstructive sleep apnea. Rossiiskii Kardiologicheskii Zhurnal = Russ J Cardiol. 2017;22(7):111-6 (In Russ.)]. doi: 10.15829/1560-4071-2017-7-111-11
2. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW; ACC/AHA Task Force Members. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. J Am Coll Cardiol. 2014;64(21):247-78. doi: 10.1161/CIR.0000000000000040
3. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P, Agewall S, Camm J, Baron Esquivias G, Budts W, Carerj S, Casselman, Coca A, De Caterina R, Deftereos S, Dobrev D, Ferro JM, Filippatos G, Fitzsimons D, Gorenek B, Guenoun M, Hohnloser SH, Kolh P, Lip GY, Manolis A, McMurray J, Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, Tamargo JL, Taylor CJ, Van Gelder IC, Voors AA, Windecker S, Zamorano JL, Zeppenfeld K. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18(11):1609-78. doi: 10.1093/europace/euw295
4. Parmon EV, Treshkur TV, Shlyahto EV. Idiopathic ventricular arrhythmias (Problem analysis). Vestnik Aritmologii. 2003;31:60-71 (In Russ.)
5. Rodionova ES, Mironova NA, Aparina OP, Rogova MM, Zykov KA, Golitsyn SP. Role of autoimmune reactions in development of cardiac arrhythmia and conduction disturbances. Therapeutic Archive. 2012;(4):74-8 (In Russ.)
6. Zaho R, Wang W, Wu B, Hoebeke J, Hjalmarson A, Fu ML. Effects of anti-peptide antibodies against the second extracellular loop of human M2 muscarinic acetylcholine receptors on transmembrane potentials and currents in guinea pig ventricular myocytes. Mol Cell Biochem J. 1994;163:185-93.
7. Stavrakis S, Kem DC. Activating autoantibodies to the beta1-adrenergic and M2 muscarinic receptors facilitate atrial fibrillation in patients with Graves’ hyperthyroidism. J Am Coll Cardiol. 2009;54:1309-16.
8. Kostyukevich MV, Zykov KA, Mironova NA, Agapova OYu, Shevelev AYa, Efremov EE, Vlasik TN, Golitsyn SP. Role of Autoantibodies Against β1-Adrenergic Receptor in Cardiovascular Disease. Kardiologiia. 2016;56(12):82-91 (In Russ.) doi: 10.18565/cardio.2016.12.82-91
9. Chazov EI. Issues in diagnosis and management of cardiovascular diseases. Therapeutic Archive. 1991;63(9):6 (In Russ.)
10. Palkeeva ME, Sidorova MV, Molokoedov AS, Az'muko AA, Bespalova ZhD, Sharf TV, Mamochkina EN, Efremov EE, Rogova MM, Mironova NA, Zykov KA, Golitsyn SP. Synthetic conformational antigen which simulates the extracellular part of the M2-muscarinic receptor: Interaction with blood sera of patients suffering from idiopathic arrhythmias. Bioorganicheskaya khimiya = Russ J Bioorg Chem. 2013;39(3):252-8 (In Russ.) doi: 10.7868/S013234231303010X
11. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997;96 (4):1180-4.
12. Morillo CA, Klein GJ, Jones DL, Guiraudon CM. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation. 1995;91(5):1588-95.
13. Aparina OP, Chikhireva LN, Mironova NA, Mironova ES, Bakalov SA. Role of atrial structural and functional changes in the development and progression of atrial fibrillation. Therapeutic Archive. 2014;86(1):71-7 (In Russ.)
14. Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen SA, Chugh SS, Corradi D, A DA, Dobrev D, Fenelon G, Gonzalez M, Hatem SN, Helm R, Hindricks G, Ho SY, Hoit B, Jalife J, Kim YH, Lip GY, Ma CS, Marcus GM, Murray K, Nogami A, Sanders P, Uribe W, van Wagoner DR, Nattel S. Ehra/hrs/aphrs/solaece expert consensus on atrial cardiomyopathies: Definition, characterisation, and clinical implication. J Arrhythm. 2016;32(4):247-78. doi: 10.1016/j.joa.2016.05.002
15. Flett AS, Hasleton J, Cook C, Hausenloy D, Quarta G, Ariti C, Muthurangu V, Moon JC. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc Imaging. 2011;4(2):150-6. doi: 10.1016/j.jcmg.2010.11.015
16. Kim RJ, Albert TS, Wible JH, Elliott MD, Allen JC, Lee JC, Parker M, Napoli A, Judd RM. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: An international, multicenter, double-blinded, randomized trial. Circulation. 2008;117(5):629-37. doi: 10.1161/CIRCULATIONAHA.107.723262
17. Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, Fish EN, Blauer JJ, Rao SN, DiBella EV, Segerson NM, Daccarett M, Windfelder J, McGann CJ, Parker D, MacLeod RS, Marrouche NF. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation. 2009;119(13):1758-67. doi: 10.1161/CIRCULATIONAHA.108.811877
18. Karim R, Housden RJ, Balasubramaniam M, Chen Z, Perry D, Uddin A, Al-Beyatti Y, Palkhi E, Acheampong P, Obom S, Hennemuth A, Lu Y, Bai W, Shi W, Gao Y, Peitgen HO, Radau P, Razavi R, Tannenbaum A, Rueckert D, Cates J, Schaeffter T, Peters D, MacLeod R, Rhode K. Evaluation of current algorithms for segmentation of scar tissue from late gadolinium enhancement cardiovascular magnetic resonance of the left atrium: An open-access grand challenge. J Cardiovasc Magn Reson. 2013;15:105. doi: 10.1186/1532-429X-15-105
19. Aparina OP, Stukalova OV, Parkhomenko DV, Mironova NA, Butorova EA, Bolotova MN, Makeev MI, Ternovoy SK, Golitsyn SP. Characteristics of left atrial myocardium structure in tarial fibrillation and healthy volunteers according to late gadolinium enhancement magnetic resonanse imaging. Vestnik Aritmologii. 2014;77:5-12 (In Russ.)
20. Aparina OP, Stukalova OV, Parkhomenko DV, Mironova NA, Strzdenj EYu, Ternovoy SK, Golitsyn SP. Structural and functional properties of the left atrium in healthy volunteers and patients with atrial fibrillation: data of madnetic resonance imaging. Kardiologiia. 2017;59(9):5-13 (In Russ.) doi: 10.18087/cardio.2017.9.10029
21. Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, Kholmovski E, Burgon N, Hu N, Mont L, Deneke T, Duytschaever M, Neumann T, Mansour M, Mahnkopf C, Herweg B, Daoud E, Wissner E, Bansmann P, Brachmann J. Association of atrial tissue fibrosis identified by delayed enhancement mri and atrial fibrillation catheter ablation: The decaaf study. JAMA. 2014;311(5):498-506. doi: 10.1001/jama.2014.3
22. Platonov PG, Mitrofanova LB, Orshanskaya V, Ho SY. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J Am Coll Cardiol. 2011;58 (21):2225-32. doi: 10.1016/j.jacc.2011.05.061
23. Kuppahally SS, Akoum N, Burgon NS, Badger TJ, Kholmovski EG, Vijayakumar S, Rao SN, Blauer J, Fish EN, Dibella EV, Macleod RS, McGann C, Litwin SE, Marrouche NF. Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: Relationship to left atrial structural remodeling detected by delayed-enhancement MRI. Circ Cardiovasc Imaging. 2010;3(3):231-9. doi: 10.1161/CIRCIMAGING.109.865683
24. Peters DC, Wylie JV, Hauser TH, Kissinger KV, Botnar RM, Essebag V, Josephson ME, Manning WJ. Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement mr imaging: Initial experience. Radiology. 2007;243 (3):690-5. doi: 10.1148/radiol.2433060417
25. Wijffels MC, Kirchhof CJ, Dorland R, et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92:1954-68.
26. Bregvadze IN, Maykov EB, Bildinov OA, Golitsyn SP. Efficacy and safety of nibentan in conversion of persistent atrial fibrillation and flutter to sinus rhythm: role of dose limitation and magnesium sulfate. Kardiologiia. 2007;(3):48-55 (In Russ.)
27. Merkulova IN, Tararak AE, Kotkin KL, Golitsyn SP, Ruda MYa. Clinical investigation of new class III antiarrhythmic drug nibentan. Message 3: Efficacy of nibentan in ventricular arrhythmias, proarrhythmic effects. Kardiologiia. 1997;(4):3-14 (In Russ.)
28. Glushkov RG, Yuzhakov SD, L'vov AI, Zhikhareva GP, Davydova NK, Sizova OS, Asnina VV, Salin EN. New group of class III antiarrhythmic drugs: Piperid-4-ylethane derivatives. Khimiko-Farmatsevticheskii Zhurnal = Pharmaceutical Chemistry Journal. 2011;45(2):65-74 (In Russ.)
29. Rosenstraukh LV, Fedorov VV, Reznik AV, Sharifov OF, Beloshapko GG, Yushmanova AV, Golitsyn SP, Ruda MYa, Chazov EI. Electrophysiological Experimental Study of a Novel Class III Antiarrhythmic Drug RG-2. Kardiologiia. 2003;43(9):56-64 (In Russ.)
30. Mironov NYu, Golitsyn SP, Sokolov SF, Maikov EB, Shlevkov NB, Yuricheva YuA, Mareev YuV, Rozenshtraukh LV, Chazov EI. Electrophysiological Effects and Antiarrhythmic Activity of Novel Domestic Class III Antiarrhythmogenic Drug Niferidil Administered in Patients with Paroxismal Supraventricular Tachycardia. Eksperimental'naya i Klinicheskaya Farmakologiya = Experimental and Clinical Pharmacology. 2012;75(10):16-21 (In Russ.)
31. Yuricheva YuA, Sokolov SF, Golitsyn SP, Mironov NYu, Rivin AE, Berman MV, Shubik YuV, Zotova IV, Zateyshchikov DA, Bolotova MN, Rozenshtraukh LV, Chazov EI. A novel III class antiarryhthmic, niferidil, as an effective medication for the sinus rhythm recovery in patients with persistent atrial fibrillation. Vestnik Aritmologii = J Arrhythmol. 2012;70:32-43 (In Russ.)
32. Mironov NYu, Vlodzyanovskiy VV, Yuricheva YuA, Sokolov SF, Golitsyn SP, Rosenstraukh LV, Chazov EI. Safety and effectiveness of electrical and pharmacological cardioversion in persistent atrial fibrillation. Part I: study rationale, design and assessment of effectiveness. Ratsional'naya Farmakoterapiya v Kardiologii = Ration Pharmacother Cardiol. 2018;14(5):664-9 (In Russ.) doi: 10.20996/1819-6446-2018-14-5-664-669
33. Mironov NYu, Vlodzyanovskiy VV, Yuricheva YuA, Sokolov SF, Golitsyn SP, Rosenstraukh LV, Chazov EI. Safety and effectiveness of electrical and pharmacological cardioversion in persistent atrial fibrillation. Part 2: assessment of safety. Ratsional'naya Farmakoterapiya v Kardiologii = Ration Pharmacother Cardiol. 2018;14(6):826-30 (In Russ.) doi: 10.20996/1819-6446-2018-14-6-826-830
34. Mironov NYu, Maykov EB, Shlevkov NB, Mareev YuV, Vlodzyanovskiy VV, Gruzdev KA, Pevzner AV. Catheter balloon cryoablation in management of paroxysmal atrial fibrillation: demonstration of clinical cases. Kardiologicheskii Vestnik = Bull Cardiol. 2014;9(2):44-52 (In Russ.)
35. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D; Heart Rhythm Society Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm. 2012;9(4):632-96. doi: 10.1016/j.hrthm.2011.12.016
36. Packer DL, Kowal RC, Wheelan KR, Irwin JM, Champagne J, Guerra PG, Dubuc M, Reddy V, Nelson L, Holcomb RG, Lehmann JW, Ruskin JN; STOP AF Cryoablation Investigators. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol. 2013;61(16):1713-23. doi: 10.1016/j.jacc.2012.11.064
37. Garg J, Chaudhary R, Palaniswamy C, Shah N, Krishnamoorthy P, Bozorgnia B, Natale A. Cryoballoon versus radiofrequency ablation for atrial fibrillation: A meta-analysis of 16 clinical trials. J Atr Fibrillation. 2016;9(3):1429. doi: 10.4022/jafib.1429
38. Ciconte G, Baltogiannis G, de Asmundis C, Sieira J, Conte G, Di Giovanni G, Saitoh Y, Irfan G, Mugnai G, Hunuk B, Chierchia GB, Brugada P. Pulmonary vein isolation as index procedure for persistent atrial fibrillation: One-year clinical outcome after ablation using the second-generation cryoballoon. Heart Rhythm. 2015;12(1):60-6. doi: 10.1016/j.hrthm.2014.09.063
39. Aryana A, Baker JH, Espinosa Ginic MA, Pujara DK, Bowers MR, O'Neill PG, Ellenbogen KA, Di Biase L, d'Avila A, Natale A. Posterior wall isolation using the cryoballoon in conjunction with pulmonary vein ablation is superior to pulmonary vein isolation alone in patients with persistent atrial fibrillation: A multicenter experience. Heart Rhythm. 2018;15(8):1121-9. doi: 10.1016/j.hrthm.2018.05.014
40. Shcherbakova NV, Meshkov AN, Boytsov SA. Exome sequencing and the diagnostics of complex disease predisposition in preventive medicine. Kardiovaskulyarnaya Terapiya i Profilaktika = Cardiovasc Ther Prof. 2013;12(6):24-8 (In Russ.)
41. Akramova EG. Characteristic of cardiac rhythm disturbances in patients with chronic obstructive pulmonary disease. Klinicheskaya Meditsina = Clinical Medicine. 2013;91(2):41-4 (In Russ.)
42. Dolgusheva YuA, Agapova OYu, Zykov KA, Chazova IE. Safety of beta-agonists with different duration of action in patients with arterial hypertension and broncho-obstructive diseases. Sistemnye Gipertenzii = Systemic Hypertension. 2015;12(1):65-9 (In Russ.)
43. Bairambekov ESh, Pevzner AV, Litvin AYu, Fomicheva OA. Atrial fibrillation and prolonged nocturnal cardiac arrests in a patient with obstructive sleep apnea syndrome. Successful correction of disorders by CPAP therapy. Therapeutic Archive. 2016;88(9):84-9 (In Russ.) doi: 10.17116/terarkh201688984-89
44. Dimitri H, Ng M, Brooks AG, Kuklik P, Stiles MK, Lau DH, Antic N, Thornton A, Saint DA, McEvoy D, Antic R, Kalman JM, Sanders P. Atrial remodeling in obstructive sleep apnea: implications for atrial fibrillation. Heart Rhythm. 2012;9(3):321-7. doi: 10.1016/j.hrthm.2011.10.017
45. Bairambekov ESh, Pevzner AV, Litvin AYu, Elfimova EM. Possibilities of diagnostics and the detection rate of obstructive sleep apnea in patients with various forms of atrial fibrillation. Kardiologicheskii Vestnik = Bull Cardiol. 2016;11(2):34-41 (In Russ.)
46. Pevzner AV, Bayrambekov ESh, Litvin AYu, Elfimova EM, Ermishkin VV, Sokolov SF, Golitsyn SP. Results of continuous positive upper airway pressure treatment in patients with atrial fibrillation and obstructive sleep apnea. Rossiiskii Kardiologicheskii Zhurnal = Russ J Cardiol. 2017;22(7):111-6 (In Russ.) doi: 10.15829/1560-4071-2017-7-111-11
2. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW; ACC/AHA Task Force Members. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. J Am Coll Cardiol. 2014;64(21):247-78. doi: 10.1161/CIR.0000000000000040
3. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P, Agewall S, Camm J, Baron Esquivias G, Budts W, Carerj S, Casselman, Coca A, De Caterina R, Deftereos S, Dobrev D, Ferro JM, Filippatos G, Fitzsimons D, Gorenek B, Guenoun M, Hohnloser SH, Kolh P, Lip GY, Manolis A, McMurray J, Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, Tamargo JL, Taylor CJ, Van Gelder IC, Voors AA, Windecker S, Zamorano JL, Zeppenfeld K. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18(11):1609-78. doi: 10.1093/europace/euw295
4. Пармон Е.В., Трешкур Т.В., Шляхто Е.В. Идиопатические желудочковые нарушения ритма (анализ проблемы). Вестник аритмологии. 2003;31:60-71 [Parmon EV, Treshkur TV, Shlyahto EV. Idiopathic ventricular arrhythmias (Problem analysis). Vestnik Aritmologii. 2003;31:60-71 (In Russ.)].
5. Родионова Е.С., Миронова Н.А., Апарина О.П., Рогова М.М., Зыков К.А., Голицын С.П. Роль аутоиммунных реакций в развитии нарушений ритма и проводимости сердца. Терапевтический архив. 2012;(4):74-8 [Rodionova ES, Mironova NA, Aparina OP, Rogova MM, Zykov KA, Golitsyn SP. Role of autoimmune reactions in development of cardiac arrhythmia and conduction disturbances. Therapeutic Archive. 2012;(4):74-8 (In Russ.)].
6. Zaho R, Wang W, Wu B, Hoebeke J, Hjalmarson A, Fu ML. Effects of anti-peptide antibodies against the second extracellular loop of human M2 muscarinic acetylcholine receptors on transmembrane potentials and currents in guinea pig ventricular myocytes. Mol Cell Biochem J. 1994;163:185-93.
7. Stavrakis S, Kem DC. Activating autoantibodies to the beta1-adrenergic and M2 muscarinic receptors facilitate atrial fibrillation in patients with Graves’ hyperthyroidism. J Am Coll Cardiol. 2009;54:1309-16.
8. Костюкевич М.В., Зыков К.А., Миронова Н.А., Агапова О.Ю., Шевелев А.Я., Ефремов Е.Е., Власик Т.Н., Голицын С.П. Роль аутоантител к β1-адренорецептору при сердечно-сосудистых заболеваниях. Кардиология. 2016;56(12):82-91 [Kostyukevich MV, Zykov KA, Mironova NA, Agapova OYu, Shevelev AYa, Efremov EE, Vlasik TN, Golitsyn SP. Role of Autoantibodies Against β1-Adrenergic Receptor in Cardiovascular Disease. Kardiologiia. 2016;56(12):82-91 (In Russ.)]. doi: 10.18565/cardio.2016.12.82-91
9. Чазов Е.И. Некоторые аспекты диагностики и лечения сердечно-сосудистых заболеваний. Терапевтический архив. 1991;63(9):6 [Chazov EI. Issues in diagnosis and management of cardiovascular diseases. Therapeutic Archive. 1991;63(9):6 (In Russ.)].
10. Палькеева М.Е., Сидорова М.В., Молокоедов А.С., Азьмуко А.А., Беспалова Ж.Д., Шарф Т.В., Мамочкина Е.Н., Ефремов Е.Е., Рогова М.М., Миронова Н.А., Зыков К.А., Голицын С.П. Синтетический конформационный антиген, моделирующий внеклеточную часть мускаринового М2-рецептора, и его взаимодействие с сыворотками крови пациентов с идиопатическими аритмиями. Биоорганическая химия. 2013;39(3):285 [Palkeeva ME, Sidorova MV, Molokoedov AS, Az'muko AA, Bespalova ZhD, Sharf TV, Mamochkina EN, Efremov EE, Rogova MM, Mironova NA, Zykov KA, Golitsyn SP. Synthetic conformational antigen which simulates the extracellular part of the M2-muscarinic receptor: Interaction with blood sera of patients suffering from idiopathic arrhythmias. Bioorganicheskaya khimiya = Russ J Bioorg Chem. 2013;39(3):252-8 (In Russ.)]. doi: 10.7868/S013234231303010X
11. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997;96 (4):1180-4.
12. Morillo CA, Klein GJ, Jones DL, Guiraudon CM. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation. 1995;91(5):1588-95.
13. Апарина О.П., Чихирева Л.Н., Миронова Н.А., Миронова Е.С., Бакалов С.А. Роль структурно-функциональных изменений предсердий в развитии и прогрессировании фибрилляции предсердий. Терапевтический архив. 2014;86(1):71-7 [Aparina OP, Chikhireva LN, Mironova NA, Mironova ES, Bakalov SA. Role of atrial structural and functional changes in the development and progression of atrial fibrillation. Therapeutic Archive. 2014;86(1):71-7 (In Russ.)].
14. Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen SA, Chugh SS, Corradi D, A DA, Dobrev D, Fenelon G, Gonzalez M, Hatem SN, Helm R, Hindricks G, Ho SY, Hoit B, Jalife J, Kim YH, Lip GY, Ma CS, Marcus GM, Murray K, Nogami A, Sanders P, Uribe W, van Wagoner DR, Nattel S. Ehra/hrs/aphrs/solaece expert consensus on atrial cardiomyopathies: Definition, characterisation, and clinical implication. J Arrhythm. 2016;32(4):247-78. doi: 10.1016/j.joa.2016.05.002
15. Flett AS, Hasleton J, Cook C, Hausenloy D, Quarta G, Ariti C, Muthurangu V, Moon JC. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc Imaging. 2011;4(2):150-6. doi: 10.1016/j.jcmg.2010.11.015
16. Kim RJ, Albert TS, Wible JH, Elliott MD, Allen JC, Lee JC, Parker M, Napoli A, Judd RM. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: An international, multicenter, double-blinded, randomized trial. Circulation. 2008;117(5):629-37. doi: 10.1161/CIRCULATIONAHA.107.723262
17. Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, Fish EN, Blauer JJ, Rao SN, DiBella EV, Segerson NM, Daccarett M, Windfelder J, McGann CJ, Parker D, MacLeod RS, Marrouche NF. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation. 2009;119(13):1758-67. doi: 10.1161/CIRCULATIONAHA.108.811877
18. Karim R, Housden RJ, Balasubramaniam M, Chen Z, Perry D, Uddin A, Al-Beyatti Y, Palkhi E, Acheampong P, Obom S, Hennemuth A, Lu Y, Bai W, Shi W, Gao Y, Peitgen HO, Radau P, Razavi R, Tannenbaum A, Rueckert D, Cates J, Schaeffter T, Peters D, MacLeod R, Rhode K. Evaluation of current algorithms for segmentation of scar tissue from late gadolinium enhancement cardiovascular magnetic resonance of the left atrium: An open-access grand challenge. J Cardiovasc Magn Reson. 2013;15:105. doi: 10.1186/1532-429X-15-105
19. Апарина ОП, Стукалова ОВ, Пархоменко ДВ, Миронова НА, Буторова ЕА, Болотова МН, Макеев МИ, Терновой СК, Голицын СП. Характеристика структуры миокарда левого предсердия у больных мерцательной аритмией и здоровых добровольцев по данным магнитно-резонансной томографии с отсроченным контрастированием. Вестник аритмологии. 2014;77:5-12 [Aparina OP, Stukalova OV, Parkhomenko DV, Mironova NA, Butorova EA, Bolotova MN, Makeev MI, Ternovoy SK, Golitsyn SP. Characteristics of left atrial myocardium structure in tarial fibrillation and healthy volunteers according to late gadolinium enhancement magnetic resonanse imaging. Vestnik Aritmologii. 2014;77:5-12 (In Russ.)].
20. Апарина О.П., Стукалова О.В., Пархоменко Д.В., Миронова Н.А., Страздень Е.Ю., Терновой С.К., Голицын С.П. Структурно-функциональные характеритики левого предсерлия у здоровых добровольцев и пациентов с фибрилляцией предсердий по данным магнитно-резонанасной томографии с отсроченным контрастированием. Кардиология. 2017;59(9):5-13 [Aparina OP, Stukalova OV, Parkhomenko DV, Mironova NA, Strzdenj EYu, Ternovoy SK, Golitsyn SP. Structural and functional properties of the left atrium in healthy volunteers and patients with atrial fibrillation: data of madnetic resonance imaging. Kardiologiia. 2017;59(9):5-13 (In Russ.)]. doi: 10.18087/cardio.2017.9.10029
21. Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, Kholmovski E, Burgon N, Hu N, Mont L, Deneke T, Duytschaever M, Neumann T, Mansour M, Mahnkopf C, Herweg B, Daoud E, Wissner E, Bansmann P, Brachmann J. Association of atrial tissue fibrosis identified by delayed enhancement mri and atrial fibrillation catheter ablation: The decaaf study. JAMA. 2014;311(5):498-506. doi: 10.1001/jama.2014.3
22. Platonov PG, Mitrofanova LB, Orshanskaya V, Ho SY. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J Am Coll Cardiol. 2011;58 (21):2225-32. doi: 10.1016/j.jacc.2011.05.061
23. Kuppahally SS, Akoum N, Burgon NS, Badger TJ, Kholmovski EG, Vijayakumar S, Rao SN, Blauer J, Fish EN, Dibella EV, Macleod RS, McGann C, Litwin SE, Marrouche NF. Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: Relationship to left atrial structural remodeling detected by delayed-enhancement MRI. Circ Cardiovasc Imaging. 2010;3(3):231-9. doi: 10.1161/CIRCIMAGING.109.865683
24. Peters DC, Wylie JV, Hauser TH, Kissinger KV, Botnar RM, Essebag V, Josephson ME, Manning WJ. Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement mr imaging: Initial experience. Radiology. 2007;243 (3):690-5. doi: 10.1148/radiol.2433060417
25. Wijffels MC, Kirchhof CJ, Dorland R, et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92:1954-68.
26. Брегвадзе И.Н., Майков Е.Б., Бильдинов О.А., Голицын С.П. Эффективность и безопасность нибентана при медикаментозной кардиоверсии у больных персистирующей формой фибрилляции и трепетания предсердий: роль ограничения доз препарата и применения магния сульфата. Кардиология. 2007;(3):48-55 [Bregvadze IN, Maykov EB, Bildinov OA, Golitsyn SP. Efficacy and safety of nibentan in conversion of persistent atrial fibrillation and flutter to sinus rhythm: role of dose limitation and magnesium sulfate. Kardiologiia. 2007;(3):48-55 (In Russ.)].
27. Меркулова И.Н., Тарарак А.Э., Коткин К.Л., Голицын С.П., Руда М.Я. Клиническое изучение нибентана – нового антиаритмического препарата III класса. Сообщение 3. Эффективность нибентана у больных с желудочковыми нарушениями ритма сердца, аритмогенные эффекты. Кардиология. 1997;(4):3-14 [Merkulova IN, Tararak AE, Kotkin KL, Golitsyn SP, Ruda MYa. Clinical investigation of new class III antiarrhythmic drug nibentan. Message 3: Efficacy of nibentan in ventricular arrhythmias, proarrhythmic effects. Kardiologiia. 1997;(4):3-14 (In Russ.)].
28. Глушков Р.Г., Южаков С.Д., Львов А.И., Жихарева Г.П., Давыдова Н.К., Сизова О.С., Аснина В.В., Салин Е.Н. Новая группа антиаритмических средств III класса – производных пиперидил-4-этана. Химико-фармацевтический журнал. 2011;45(2):3-12 [Glushkov RG, Yuzhakov SD, L'vov AI, Zhikhareva GP, Davydova NK, Sizova OS, Asnina VV, Salin EN. New group of class III antiarrhythmic drugs: Piperid-4-ylethane derivatives. Khimiko-Farmatsevticheskii Zhurnal = Pharmaceutical Chemistry Journal. 2011;45(2):65-74 (In Russ.)].
29. Розенштраух Л.В., Федоров В.В., Резник А.В., Шарифов О.Ф., Белошапко Г.Г., Юшманова А.В., Голицын С.П., Руда М.Я., Чазов Е.И. Экспериментальное электрофизиологическое исследование препарата III класса РГ-2. Кардиология. 2003;43(9):56-64 [Rosenstraukh LV, Fedorov VV, Reznik AV, Sharifov OF, Beloshapko GG, Yushmanova AV, Golitsyn SP, Ruda MYa, Chazov EI. Electrophysiological Experimental Study of a Novel Class III Antiarrhythmic Drug RG-2. Kardiologiia. 2003;43(9):56-64 (In Russ.)].
30. Миронов Н.Ю., Голицын С.П., Соколов С.Ф., Майков Е.Б., Шлевков Н.Б., Юричева Ю.А., Мареев Ю.В., Розенштраух Л.В., Чазов Е.И. Электрофизиологические эффекты и противоаритмическая активность нового отечественного антиаритмического препарата III класса ниферидила у больных пароксизмальными наджелудочковыми тахикардиями. Экспериментальная и клиническая фармакология. 2012;75(10):16-21 [Mironov NYu, Golitsyn SP, Sokolov SF, Maikov EB, Shlevkov NB, Yuricheva YuA, Mareev YuV, Rozenshtraukh LV, Chazov EI. Electrophysiological Effects and Antiarrhythmic Activity of Novel Domestic Class III Antiarrhythmogenic Drug Niferidil Administered in Patients with Paroxismal Supraventricular Tachycardia. Eksperimental'naya i Klinicheskaya Farmakologiya = Experimental and Clinical Pharmacology. 2012;75(10):16-21 (In Russ.)].
31. Юричева Ю.А., Соколов С.Ф., Голицын С.П., Миронов Н.Ю., Ривин А.Е., Берман М.В., Шубик Ю.В., Зотова И.В., Затейщиков Д.А., Болотова М.Н., Розенштраух Л.В., Чазов Е.И. Новый антиаритмический препарат III класса ниферидил как эффективное средство восстановления синусового ритма при персистирующей форме мерцательной аритмии. Вестник аритмологии. 2012;70:32-43 [Yuricheva YuA, Sokolov SF, Golitsyn SP, Mironov NYu, Rivin AE, Berman MV, Shubik YuV, Zotova IV, Zateyshchikov DA, Bolotova MN, Rozenshtraukh LV, Chazov EI. A novel III class antiarryhthmic, niferidil, as an effective medication for the sinus rhythm recovery in patients with persistent atrial fibrillation. Vestnik Aritmologii = J Arrhythmol. 2012;70:32-43 (In Russ.)].
32. Миронов Н.Ю., Влодзяновский В.В., Юричева Ю.А., Соколов С.Ф., Голицын С.П., Розенштраух Л.В., Чазов Е.И. Проспективное рандомизированное исследование эффективности и безопасности электрической и медикаментозной кардиоверсии при персистирующей фибрилляции предсердий. Часть 1: методология исследования и оценка эффективности. Рациональная фармакотерапия в кардиологии. 2018;14(5):664-9 [Mironov NYu, Vlodzyanovskiy VV, Yuricheva YuA, Sokolov SF, Golitsyn SP, Rosenstraukh LV, Chazov EI. Safety and effectiveness of electrical and pharmacological cardioversion in persistent atrial fibrillation. Part I: study rationale, design and assessment of effectiveness. Ratsional'naya Farmakoterapiya v Kardiologii = Ration Pharmacother Cardiol. 2018;14(5):664-9 (In Russ.)]. doi: 10.20996/1819-6446-2018-14-5-664-669
33. Миронов Н.Ю., Влодзяновский В.В., Юричева Ю.А., Соколов С.Ф., Голицын С.П., Розенштраух Л.В., Чазов Е.И. Проспективное рандомизированное исследование эффективности и безопасности электрической и медикаментозной кардиоверсии при персистирующей фибрилляции предсердий. Часть 2: оценка безопасности. Рациональная фармакотерапия в кардиологии. 2018;14(6):826-30 [Mironov NYu, Vlodzyanovskiy VV, Yuricheva YuA, Sokolov SF, Golitsyn SP, Rosenstraukh LV, Chazov EI. Safety and effectiveness of electrical and pharmacological cardioversion in persistent atrial fibrillation. Part 2: assessment of safety. Ratsional'naya Farmakoterapiya v Kardiologii = Ration Pharmacother Cardiol. 2018;14(6):826-30 (In Russ.)]. doi: 10.20996/1819-6446-2018-14-6-826-830
34. Миронов Н.Ю., Майков Е.Б., Шлевков Н.Б., Мареев Ю.В., Влодзяновский, Груздев К.А., Певзнер А.В. Катетерная баллонная криоаблация в лечении пароксизмальной формы фибрилляции предсердий: клиническая демонстрация возможностей методики. Кардиологический вестник. 2014;9(2):44-52 [Mironov NYu, Maykov EB, Shlevkov NB, Mareev YuV, Vlodzyanovskiy VV, Gruzdev KA, Pevzner AV. Catheter balloon cryoablation in management of paroxysmal atrial fibrillation: demonstration of clinical cases. Kardiologicheskii Vestnik = Bull Cardiol. 2014;9(2):44-52 (In Russ.)].
35. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D; Heart Rhythm Society Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm. 2012;9(4):632-96. doi: 10.1016/j.hrthm.2011.12.016
36. Packer DL, Kowal RC, Wheelan KR, Irwin JM, Champagne J, Guerra PG, Dubuc M, Reddy V, Nelson L, Holcomb RG, Lehmann JW, Ruskin JN; STOP AF Cryoablation Investigators. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol. 2013;61(16):1713-23. doi: 10.1016/j.jacc.2012.11.064
37. Garg J, Chaudhary R, Palaniswamy C, Shah N, Krishnamoorthy P, Bozorgnia B, Natale A. Cryoballoon versus radiofrequency ablation for atrial fibrillation: A meta-analysis of 16 clinical trials. J Atr Fibrillation. 2016;9(3):1429. doi: 10.4022/jafib.1429
38. Ciconte G, Baltogiannis G, de Asmundis C, Sieira J, Conte G, Di Giovanni G, Saitoh Y, Irfan G, Mugnai G, Hunuk B, Chierchia GB, Brugada P. Pulmonary vein isolation as index procedure for persistent atrial fibrillation: One-year clinical outcome after ablation using the second-generation cryoballoon. Heart Rhythm. 2015;12(1):60-6. doi: 10.1016/j.hrthm.2014.09.063
39. Aryana A, Baker JH, Espinosa Ginic MA, Pujara DK, Bowers MR, O'Neill PG, Ellenbogen KA, Di Biase L, d'Avila A, Natale A. Posterior wall isolation using the cryoballoon in conjunction with pulmonary vein ablation is superior to pulmonary vein isolation alone in patients with persistent atrial fibrillation: A multicenter experience. Heart Rhythm. 2018;15(8):1121-9. doi: 10.1016/j.hrthm.2018.05.014
40. Щербакова Н.В., Мешков А.Н., Бойцов С.А. Применение метода секвенирования экзомов для диагностики предрасположенности к комплексным заболеваниям в профилактической медицине. Кардиоваскулярная терапия и профилактика. 2013;12(6):24-8 [Shcherbakova NV, Meshkov AN, Boytsov SA. Exome sequencing and the diagnostics of complex disease predisposition in preventive medicine. Kardiovaskulyarnaya Terapiya i Profilaktika = Cardiovasc Ther Prof. 2013;12(6):24-8 (In Russ.)].
41. Акрамова Э.Г. Характеристика нарушений ритма сердца у больных хронической обструктивной болезнью легких. Клиническая медицина. 2013;91(2):41-4 [Akramova EG. Characteristic of cardiac rhythm disturbances in patients with chronic obstructive pulmonary disease. Klinicheskaya Meditsina = Clinical Medicine. 2013;91(2):41-4 (In Russ.)].
42. Долгушева Ю.А., Агапова О.Ю., Зыков К.А., Чазова И.Е. Безопасность применения β-адреномиметиков разной длительности действия у пациентов с артериальной гипертонией в сочетании с бронхообструктивными заболеваниями. Системные гипертензии. 2015;12(1):65-9 [Dolgusheva YuA, Agapova OYu, Zykov KA, Chazova IE. Safety of beta-agonists with different duration of action in patients with arterial hypertension and broncho-obstructive diseases. Sistemnye Gipertenzii = Systemic Hypertension. 2015;12(1):65-9 (In Russ.)].
43. Байрамбеков Э.Ш., Певзнер А.В., Литвин А.Ю., Фомичева О.А. Фибрилляция предсердий и длительные ночные "остановки" сердца у больного с синдромом обструктивного апноэ во сне. успешная коррекция нарушений при применении СИПАП-терапии. Терапевтический архив. 2016;88(9):84-9 [Bairambekov ESh, Pevzner AV, Litvin AYu, Fomicheva OA. Atrial fibrillation and prolonged nocturnal cardiac arrests in a patient with obstructive sleep apnea syndrome. Successful correction of disorders by CPAP therapy. Therapeutic Archive. 2016;88(9):84-9 (In Russ.)]. doi: 10.17116/terarkh201688984-89
44. Dimitri H, Ng M, Brooks AG, Kuklik P, Stiles MK, Lau DH, Antic N, Thornton A, Saint DA, McEvoy D, Antic R, Kalman JM, Sanders P. Atrial remodeling in obstructive sleep apnea: implications for atrial fibrillation. Heart Rhythm. 2012;9(3):321-7. doi: 10.1016/j.hrthm.2011.10.017
45. Байрамбеков Э.Ш., Певзнер А.В., Литвин А.Ю., Елфимова Е.М. Возможности диагностики и частота выявления синдрома обструктивного апноэ во время сна у больных с различными формами фибрилляции предсердий. Кардиологический вестник. 2016;11(2):34-41 [Bairambekov ESh, Pevzner AV, Litvin AYu, Elfimova EM. Possibilities of diagnostics and the detection rate of obstructive sleep apnea in patients with various forms of atrial fibrillation. Kardiologicheskii Vestnik = Bull Cardiol. 2016;11(2):34-41 (In Russ.)].
46. Певзнер А.В., Байрамбеков Э.Ш., Литвин А.Ю., Елфимова Е.М., Ермишкин В.В., Соколов С.Ф., Голицын С.П. Результаты применения терапии с созданием постоянного положительного давления воздуха в верхних дыхательных путях при лечении больных с фибрилляцией предсердий и синдромом обструктивного апноэ во время сна. Российский кардиологический журнал. 2017;22(7):111-6 [Pevzner AV, Bayrambekov ESh, Litvin AYu, Elfimova EM, Ermishkin VV, Sokolov SF, Golitsyn SP. Results of continuous positive upper airway pressure treatment in patients with atrial fibrillation and obstructive sleep apnea. Rossiiskii Kardiologicheskii Zhurnal = Russ J Cardiol. 2017;22(7):111-6 (In Russ.)]. doi: 10.15829/1560-4071-2017-7-111-11
________________________________________________
2. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW; ACC/AHA Task Force Members. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. J Am Coll Cardiol. 2014;64(21):247-78. doi: 10.1161/CIR.0000000000000040
3. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P, Agewall S, Camm J, Baron Esquivias G, Budts W, Carerj S, Casselman, Coca A, De Caterina R, Deftereos S, Dobrev D, Ferro JM, Filippatos G, Fitzsimons D, Gorenek B, Guenoun M, Hohnloser SH, Kolh P, Lip GY, Manolis A, McMurray J, Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, Tamargo JL, Taylor CJ, Van Gelder IC, Voors AA, Windecker S, Zamorano JL, Zeppenfeld K. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18(11):1609-78. doi: 10.1093/europace/euw295
4. Parmon EV, Treshkur TV, Shlyahto EV. Idiopathic ventricular arrhythmias (Problem analysis). Vestnik Aritmologii. 2003;31:60-71 (In Russ.)
5. Rodionova ES, Mironova NA, Aparina OP, Rogova MM, Zykov KA, Golitsyn SP. Role of autoimmune reactions in development of cardiac arrhythmia and conduction disturbances. Therapeutic Archive. 2012;(4):74-8 (In Russ.)
6. Zaho R, Wang W, Wu B, Hoebeke J, Hjalmarson A, Fu ML. Effects of anti-peptide antibodies against the second extracellular loop of human M2 muscarinic acetylcholine receptors on transmembrane potentials and currents in guinea pig ventricular myocytes. Mol Cell Biochem J. 1994;163:185-93.
7. Stavrakis S, Kem DC. Activating autoantibodies to the beta1-adrenergic and M2 muscarinic receptors facilitate atrial fibrillation in patients with Graves’ hyperthyroidism. J Am Coll Cardiol. 2009;54:1309-16.
8. Kostyukevich MV, Zykov KA, Mironova NA, Agapova OYu, Shevelev AYa, Efremov EE, Vlasik TN, Golitsyn SP. Role of Autoantibodies Against β1-Adrenergic Receptor in Cardiovascular Disease. Kardiologiia. 2016;56(12):82-91 (In Russ.) doi: 10.18565/cardio.2016.12.82-91
9. Chazov EI. Issues in diagnosis and management of cardiovascular diseases. Therapeutic Archive. 1991;63(9):6 (In Russ.)
10. Palkeeva ME, Sidorova MV, Molokoedov AS, Az'muko AA, Bespalova ZhD, Sharf TV, Mamochkina EN, Efremov EE, Rogova MM, Mironova NA, Zykov KA, Golitsyn SP. Synthetic conformational antigen which simulates the extracellular part of the M2-muscarinic receptor: Interaction with blood sera of patients suffering from idiopathic arrhythmias. Bioorganicheskaya khimiya = Russ J Bioorg Chem. 2013;39(3):252-8 (In Russ.) doi: 10.7868/S013234231303010X
11. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997;96 (4):1180-4.
12. Morillo CA, Klein GJ, Jones DL, Guiraudon CM. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation. 1995;91(5):1588-95.
13. Aparina OP, Chikhireva LN, Mironova NA, Mironova ES, Bakalov SA. Role of atrial structural and functional changes in the development and progression of atrial fibrillation. Therapeutic Archive. 2014;86(1):71-7 (In Russ.)
14. Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen SA, Chugh SS, Corradi D, A DA, Dobrev D, Fenelon G, Gonzalez M, Hatem SN, Helm R, Hindricks G, Ho SY, Hoit B, Jalife J, Kim YH, Lip GY, Ma CS, Marcus GM, Murray K, Nogami A, Sanders P, Uribe W, van Wagoner DR, Nattel S. Ehra/hrs/aphrs/solaece expert consensus on atrial cardiomyopathies: Definition, characterisation, and clinical implication. J Arrhythm. 2016;32(4):247-78. doi: 10.1016/j.joa.2016.05.002
15. Flett AS, Hasleton J, Cook C, Hausenloy D, Quarta G, Ariti C, Muthurangu V, Moon JC. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc Imaging. 2011;4(2):150-6. doi: 10.1016/j.jcmg.2010.11.015
16. Kim RJ, Albert TS, Wible JH, Elliott MD, Allen JC, Lee JC, Parker M, Napoli A, Judd RM. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: An international, multicenter, double-blinded, randomized trial. Circulation. 2008;117(5):629-37. doi: 10.1161/CIRCULATIONAHA.107.723262
17. Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, Fish EN, Blauer JJ, Rao SN, DiBella EV, Segerson NM, Daccarett M, Windfelder J, McGann CJ, Parker D, MacLeod RS, Marrouche NF. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation. 2009;119(13):1758-67. doi: 10.1161/CIRCULATIONAHA.108.811877
18. Karim R, Housden RJ, Balasubramaniam M, Chen Z, Perry D, Uddin A, Al-Beyatti Y, Palkhi E, Acheampong P, Obom S, Hennemuth A, Lu Y, Bai W, Shi W, Gao Y, Peitgen HO, Radau P, Razavi R, Tannenbaum A, Rueckert D, Cates J, Schaeffter T, Peters D, MacLeod R, Rhode K. Evaluation of current algorithms for segmentation of scar tissue from late gadolinium enhancement cardiovascular magnetic resonance of the left atrium: An open-access grand challenge. J Cardiovasc Magn Reson. 2013;15:105. doi: 10.1186/1532-429X-15-105
19. Aparina OP, Stukalova OV, Parkhomenko DV, Mironova NA, Butorova EA, Bolotova MN, Makeev MI, Ternovoy SK, Golitsyn SP. Characteristics of left atrial myocardium structure in tarial fibrillation and healthy volunteers according to late gadolinium enhancement magnetic resonanse imaging. Vestnik Aritmologii. 2014;77:5-12 (In Russ.)
20. Aparina OP, Stukalova OV, Parkhomenko DV, Mironova NA, Strzdenj EYu, Ternovoy SK, Golitsyn SP. Structural and functional properties of the left atrium in healthy volunteers and patients with atrial fibrillation: data of madnetic resonance imaging. Kardiologiia. 2017;59(9):5-13 (In Russ.) doi: 10.18087/cardio.2017.9.10029
21. Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, Kholmovski E, Burgon N, Hu N, Mont L, Deneke T, Duytschaever M, Neumann T, Mansour M, Mahnkopf C, Herweg B, Daoud E, Wissner E, Bansmann P, Brachmann J. Association of atrial tissue fibrosis identified by delayed enhancement mri and atrial fibrillation catheter ablation: The decaaf study. JAMA. 2014;311(5):498-506. doi: 10.1001/jama.2014.3
22. Platonov PG, Mitrofanova LB, Orshanskaya V, Ho SY. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J Am Coll Cardiol. 2011;58 (21):2225-32. doi: 10.1016/j.jacc.2011.05.061
23. Kuppahally SS, Akoum N, Burgon NS, Badger TJ, Kholmovski EG, Vijayakumar S, Rao SN, Blauer J, Fish EN, Dibella EV, Macleod RS, McGann C, Litwin SE, Marrouche NF. Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: Relationship to left atrial structural remodeling detected by delayed-enhancement MRI. Circ Cardiovasc Imaging. 2010;3(3):231-9. doi: 10.1161/CIRCIMAGING.109.865683
24. Peters DC, Wylie JV, Hauser TH, Kissinger KV, Botnar RM, Essebag V, Josephson ME, Manning WJ. Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement mr imaging: Initial experience. Radiology. 2007;243 (3):690-5. doi: 10.1148/radiol.2433060417
25. Wijffels MC, Kirchhof CJ, Dorland R, et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92:1954-68.
26. Bregvadze IN, Maykov EB, Bildinov OA, Golitsyn SP. Efficacy and safety of nibentan in conversion of persistent atrial fibrillation and flutter to sinus rhythm: role of dose limitation and magnesium sulfate. Kardiologiia. 2007;(3):48-55 (In Russ.)
27. Merkulova IN, Tararak AE, Kotkin KL, Golitsyn SP, Ruda MYa. Clinical investigation of new class III antiarrhythmic drug nibentan. Message 3: Efficacy of nibentan in ventricular arrhythmias, proarrhythmic effects. Kardiologiia. 1997;(4):3-14 (In Russ.)
28. Glushkov RG, Yuzhakov SD, L'vov AI, Zhikhareva GP, Davydova NK, Sizova OS, Asnina VV, Salin EN. New group of class III antiarrhythmic drugs: Piperid-4-ylethane derivatives. Khimiko-Farmatsevticheskii Zhurnal = Pharmaceutical Chemistry Journal. 2011;45(2):65-74 (In Russ.)
29. Rosenstraukh LV, Fedorov VV, Reznik AV, Sharifov OF, Beloshapko GG, Yushmanova AV, Golitsyn SP, Ruda MYa, Chazov EI. Electrophysiological Experimental Study of a Novel Class III Antiarrhythmic Drug RG-2. Kardiologiia. 2003;43(9):56-64 (In Russ.)
30. Mironov NYu, Golitsyn SP, Sokolov SF, Maikov EB, Shlevkov NB, Yuricheva YuA, Mareev YuV, Rozenshtraukh LV, Chazov EI. Electrophysiological Effects and Antiarrhythmic Activity of Novel Domestic Class III Antiarrhythmogenic Drug Niferidil Administered in Patients with Paroxismal Supraventricular Tachycardia. Eksperimental'naya i Klinicheskaya Farmakologiya = Experimental and Clinical Pharmacology. 2012;75(10):16-21 (In Russ.)
31. Yuricheva YuA, Sokolov SF, Golitsyn SP, Mironov NYu, Rivin AE, Berman MV, Shubik YuV, Zotova IV, Zateyshchikov DA, Bolotova MN, Rozenshtraukh LV, Chazov EI. A novel III class antiarryhthmic, niferidil, as an effective medication for the sinus rhythm recovery in patients with persistent atrial fibrillation. Vestnik Aritmologii = J Arrhythmol. 2012;70:32-43 (In Russ.)
32. Mironov NYu, Vlodzyanovskiy VV, Yuricheva YuA, Sokolov SF, Golitsyn SP, Rosenstraukh LV, Chazov EI. Safety and effectiveness of electrical and pharmacological cardioversion in persistent atrial fibrillation. Part I: study rationale, design and assessment of effectiveness. Ratsional'naya Farmakoterapiya v Kardiologii = Ration Pharmacother Cardiol. 2018;14(5):664-9 (In Russ.) doi: 10.20996/1819-6446-2018-14-5-664-669
33. Mironov NYu, Vlodzyanovskiy VV, Yuricheva YuA, Sokolov SF, Golitsyn SP, Rosenstraukh LV, Chazov EI. Safety and effectiveness of electrical and pharmacological cardioversion in persistent atrial fibrillation. Part 2: assessment of safety. Ratsional'naya Farmakoterapiya v Kardiologii = Ration Pharmacother Cardiol. 2018;14(6):826-30 (In Russ.) doi: 10.20996/1819-6446-2018-14-6-826-830
34. Mironov NYu, Maykov EB, Shlevkov NB, Mareev YuV, Vlodzyanovskiy VV, Gruzdev KA, Pevzner AV. Catheter balloon cryoablation in management of paroxysmal atrial fibrillation: demonstration of clinical cases. Kardiologicheskii Vestnik = Bull Cardiol. 2014;9(2):44-52 (In Russ.)
35. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D; Heart Rhythm Society Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm. 2012;9(4):632-96. doi: 10.1016/j.hrthm.2011.12.016
36. Packer DL, Kowal RC, Wheelan KR, Irwin JM, Champagne J, Guerra PG, Dubuc M, Reddy V, Nelson L, Holcomb RG, Lehmann JW, Ruskin JN; STOP AF Cryoablation Investigators. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol. 2013;61(16):1713-23. doi: 10.1016/j.jacc.2012.11.064
37. Garg J, Chaudhary R, Palaniswamy C, Shah N, Krishnamoorthy P, Bozorgnia B, Natale A. Cryoballoon versus radiofrequency ablation for atrial fibrillation: A meta-analysis of 16 clinical trials. J Atr Fibrillation. 2016;9(3):1429. doi: 10.4022/jafib.1429
38. Ciconte G, Baltogiannis G, de Asmundis C, Sieira J, Conte G, Di Giovanni G, Saitoh Y, Irfan G, Mugnai G, Hunuk B, Chierchia GB, Brugada P. Pulmonary vein isolation as index procedure for persistent atrial fibrillation: One-year clinical outcome after ablation using the second-generation cryoballoon. Heart Rhythm. 2015;12(1):60-6. doi: 10.1016/j.hrthm.2014.09.063
39. Aryana A, Baker JH, Espinosa Ginic MA, Pujara DK, Bowers MR, O'Neill PG, Ellenbogen KA, Di Biase L, d'Avila A, Natale A. Posterior wall isolation using the cryoballoon in conjunction with pulmonary vein ablation is superior to pulmonary vein isolation alone in patients with persistent atrial fibrillation: A multicenter experience. Heart Rhythm. 2018;15(8):1121-9. doi: 10.1016/j.hrthm.2018.05.014
40. Shcherbakova NV, Meshkov AN, Boytsov SA. Exome sequencing and the diagnostics of complex disease predisposition in preventive medicine. Kardiovaskulyarnaya Terapiya i Profilaktika = Cardiovasc Ther Prof. 2013;12(6):24-8 (In Russ.)
41. Akramova EG. Characteristic of cardiac rhythm disturbances in patients with chronic obstructive pulmonary disease. Klinicheskaya Meditsina = Clinical Medicine. 2013;91(2):41-4 (In Russ.)
42. Dolgusheva YuA, Agapova OYu, Zykov KA, Chazova IE. Safety of beta-agonists with different duration of action in patients with arterial hypertension and broncho-obstructive diseases. Sistemnye Gipertenzii = Systemic Hypertension. 2015;12(1):65-9 (In Russ.)
43. Bairambekov ESh, Pevzner AV, Litvin AYu, Fomicheva OA. Atrial fibrillation and prolonged nocturnal cardiac arrests in a patient with obstructive sleep apnea syndrome. Successful correction of disorders by CPAP therapy. Therapeutic Archive. 2016;88(9):84-9 (In Russ.) doi: 10.17116/terarkh201688984-89
44. Dimitri H, Ng M, Brooks AG, Kuklik P, Stiles MK, Lau DH, Antic N, Thornton A, Saint DA, McEvoy D, Antic R, Kalman JM, Sanders P. Atrial remodeling in obstructive sleep apnea: implications for atrial fibrillation. Heart Rhythm. 2012;9(3):321-7. doi: 10.1016/j.hrthm.2011.10.017
45. Bairambekov ESh, Pevzner AV, Litvin AYu, Elfimova EM. Possibilities of diagnostics and the detection rate of obstructive sleep apnea in patients with various forms of atrial fibrillation. Kardiologicheskii Vestnik = Bull Cardiol. 2016;11(2):34-41 (In Russ.)
46. Pevzner AV, Bayrambekov ESh, Litvin AYu, Elfimova EM, Ermishkin VV, Sokolov SF, Golitsyn SP. Results of continuous positive upper airway pressure treatment in patients with atrial fibrillation and obstructive sleep apnea. Rossiiskii Kardiologicheskii Zhurnal = Russ J Cardiol. 2017;22(7):111-6 (In Russ.) doi: 10.15829/1560-4071-2017-7-111-11
Авторы
Н.Ю. Миронов, Л.Ю. Лайович, Е.С. Миронова, Т.В. Шарф, О.П. Апарина, Н.А. Миронова, О.В. Стукалова, Ю.А. Юричева, С.Ф. Соколов, И.А. Новиков, Е.Б. Майков, А.В. Певзнер, С.П. Голицын
ФГБУ «Национальный медицинский исследовательский центр кардиологии» Минздрава России, Москва, Россия
National Medical Research Center in Cardiology, Moscow, Russia
ФГБУ «Национальный медицинский исследовательский центр кардиологии» Минздрава России, Москва, Россия
________________________________________________
National Medical Research Center in Cardiology, Moscow, Russia
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.